Skip to main content
Caplight Logo









Allegro Ophthalmics

Allegro Ophthalmics

Private
San Juan Capistrano, CaliforniaHealthcare & Life Scienceshttps://www.allegroeye.com/

Last Round

VC Round

Jul 24, 2017

Total Funding Raised

$22.65M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Allegro Ophthalmics is a biopharmaceutical company that develops novel therapies for ocular diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Revenue Share

AI Layer

Non-AI

Keywords

dry AMDrisuteganibmitochondrial stabilizersophthalmic drugsage-related macular degenerationAMDdry eye diseaseDEDclinical stage pharmabiotechvision loss reversalpharma licensingintravitreal injectionvitreoretinal diseaseoxidative stress reductionophthalmology

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Allegro Ophthalmics Comparables

Compare Allegro Ophthalmics with similar companies based on industry and business-model similarity.

Allegro Ophthalmics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Morningside
84%
Drusolv Therapeutics
78%
AsclepiX Therapeutics
78%

Allegro Ophthalmics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 24, 2017
GrantFeb 3, 2015
Series BJan 13, 2015

Key People

Founding team and executive leadership

Vicken Karageozian

Chief Executive Officer And President

Executive Team

Allegro Ophthalmics Investors

Notable investors and investment history

Allegro Ophthalmics investors
InvestorRounds
Helmsley Charitable TrustGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 28, 2026

    Monthly visitors increased 30% MoM.

  • Jan 8, 2026

    Monthly visitors grew 340% MoM, reaching 1.3K.

Allegro Ophthalmics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Allegro Ophthalmics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Allegro Ophthalmics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSan Juan Capistrano, California
Employee Range3
Year Founded2011
Last FundingJul 24, 2017

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?